Evolution of an immune suppressive macrophage phenotype as a product of p38 MAPK activation in polymicrobial sepsis

Shock

Volumn 15, Issue 1, 2001, Pages 42-48

  Song, Grace Y ^b   Chung, Chun Shiang ^b   Jarrar, Doraid ^b   Chaudry, Irshad H ^b   Ayala, Alfred ^a  

^a RHODE ISLAND HOSPITAL   (United States)

^b NONE

Author keywords

Cecal ligation and puncture; Immune suppression; Macrophage; Mouse; Sepsis

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ENZYME INHIBITOR; IMIDAZOLE DERIVATIVE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PYRIDINE DERIVATIVE;

ANIMAL; ARTICLE; C3H MOUSE; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; IMMUNOLOGY; MACROPHAGE; MALE; METABOLISM; MORTALITY; MOUSE; SEPSIS; SURVIVAL RATE;

ANIMALS; ENZYME ACTIVATION; ENZYME INHIBITORS; IMIDAZOLES; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MICE; MICE, INBRED C3H; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRIDINES; SEPSIS; SURVIVAL RATE;

EID: 0035229054     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200115010-00007     Document Type: Article

References (43)

1. Mannick JA: Trauma, sepsis and immune defects. In Faist E, Meakins JL, Schildberg FW (eds): Host Defense Dysfunction in Trauma, Shock, and Sepsis. Berlin: Springer-Verlag, 1993, pp 15-21.
2. Baue AE: Multiple organ failure. Patient Care and Prevention. St. Louis: Mosby, 1990.
3. Neidhardt R, Jeel M, Steckholzer U, Safret A, Ungethuem U, Trentz O, Ertel W: Relationship of interleukin-10 plasma levels to severity of injury and clinical outcome in injured patients. J Trauma 42:863-871, 1997.
4. Lyons A, Kelly JL, Rodrick ML, Mannick JA, Lederer JA: Major injury induces increased production of interleukin-10 by cells of the immune system with a negative impact on resistance to infection. Ann Surgery 226:450-460, 1997.
5. Bermudez LE, Champsi J: Infection with Mycobacterium avium induces production of interleukin-10 (IL-10), and administration of anti-IL-10 antibody is associated with enhanced resistance to infection in mice. Infect Immun 61:3093-3097, 1993.
6. O'Suilleabhain C, O'Sullivan ST, Kelly JL, Lederer J, Mannick JA, Rodrick ML: Interleukin-12 treatment restores normal resistance to bacterial challenge after burn injury. Surgery 120:290-296, 1996.
7. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys JR, Landvatter SW, Strickler JE, McLaughlin MM, Siemens IR, Fiser SM, Livi GP, White JR, Adams JL, Young PR: A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372:739-746, 1994.
8. Lee JC, Young PR: Role of CSB/p38/RK stress response kinase in LPS and cytokine signaling mechanisms. J Leuko Biol 59:152-157, 1996.
9. Han J, Jiang Y, Li Z, Kravchenko VV, Ulevitch RJ: Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature 386:296-299, 1997.
10. Shapiro L, Heidenreich KA, Meintzer MK, Dinarello CA: Role of p38 mitogen-activated protein kinase in HIV type 1 production in vitro. Proc Natl Acad Sci USA 95:7422-7426, 1998.
11. Kumar S, Orsini MJ, Lee JC, McDonnell PC, Debouck C, Young PR: Activation of the HIV-1 long terminal repeat by cytokines and environmental stress requires an active CSBP/p38 MAP kinase. J Biol Chem 271:30864-30869, 1996.
12. Baker CC, Chaudry IH, Gaines HO, Baue AE: Evaluation of factors affecting mortality rate after sepsis in murine cecal ligation and puncture model. Surgery 94:331-335, 1983.
13. Ayala A Perrin MM, Kisala JM, Ertel W, Chaudry IH: Polymicrobial sepsis selectively activates peritoneal but not alveolar macrophage to release inflammatory mediators (IL-1, IL-6 and TNF). Circ Shock 36:191-199, 1992.
14. Ayala A, Chaudry IH: Hemorrhage induces a reduction in the capacity of macrophages to mobilize intracellular calcium secondary to formyl-methionyl-leucyl-phenylalanine stimulation: association with alterations in cell surface Fc receptor expression and increased prostaglandin release. Shock 1:228-235, 1994.
15. Ayala A, Perrin MM, Chaudry IH: Defective macrophage antigen presentation following haemorrhage is associated with the loss of MHC class II (Ia) antigens. Immunology 70:33-39, 1990.
16. Ayala A, Perrin MM, Kisala JM, Ertel W, Chaudry IH: Polymicrobial sepsis selectively activates peritoneal but not alveolar macrophages to release inflammatory mediators (interleukins-1 and -6 and tumor necrosis factor). Circ Shock 36:191-199, 1992.
17. Spiecker M, Peng HB, Liao JK: Inhibition of endothelial vascular cell adhesion molecule-1 expression by nitric oxide involves the induction and nuclear translocation of IκB-α. J Biol Chem 272:30969-30974, 1997.
18. Song GY, Chung CS, Schwacha MG, Jarrar D, Chaudry IH, Ayala A: Splenic immune suppression in sepsis: a role for IL-10 induced changes in P38 MAPK signaling. J Surg Res 83:36-43, 1999.
19. Badger AM, Bradbeer JN, Votta B, Lee JC, Adams JL, Griswold DE: Pharmacological profile of SB203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. J Pharmacol Exp Therap 279:1453-1461, 1995.
20. Ayala A, Deol ZK, Lehman DL, Herdon CD, Chaudry IH: Does endotoxin play a major role in inducing the depression of macrophage function during polymicrobial sepsis? Arch Surg 130:1178-1185, 1995.
21. Gallinaro RN, Naziri W, McMasters KM, Peyton JC, Cheadle WG: Alteration of mononuclear cell immune-associated antigen expression, interleukin-1 expression, and antigen presentation during intra-abdominal infection. Shock 1:130-134, 1994.
22. Song GY, Chung CS, Chaudry IH, Ayala A: What is IL-10′s role in polymicrobial sepsis: anti-inflammatory agent or immune suppressant? Surgery 126:378-383, 1999.
23. Ayala A, Deol ZK, Lehman DL, Herdon CD, Chaudry IH: Polymicrobial sepsis but not low dose endotoxin infusion causes decreased splenocyte IL-2/IFN-γ release while increasing IL-4/IL-10 production. J Surg Res 56:579-585, 1994.
24. O'Sullivan ST, Lederer JA, Horgan AF, Chin DHL, Mannick JA, Rodrick ML: Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann Surg 222:482-492, 1995.
25. DiPiro JT, Howdieshell TR, Goddard JK, Callaywa DB, Hamilton RG, Mansberger AR: Association of interleukin-4 plasma levels with traumatic injury and clinical course. Arch Surg 130:1159-1163, 1998.
26. Ertel W, Morrison MH, Wang P, Ba ZF, Ayala A, Chaudry IH: The complex pattern of cytokines in sepsis: association between prostaglandins, cachectin and interleukins. Ann Surg 214:141-148, 1991.
27. Hadjiminas DJ, McMasters KM, Peyton JC, Cheadle WG: Tissue tumor necrosis factor mRNA expression following cecal ligation and puncture or intraperitoneal injection of endotoxin. J Surg Res 56:549-555, 1994.
28. Ayala A, Knotts JB, Ertel W, Perrin MM, Morrison MH, Chaudry IH: Role of interleukin 6 and transforming growth factor-β in the induction of depressed splenocyte responses following sepsis. Arch Surg 128:89-95, 1993.
29. Eskandari MK, Bolgos G, Miller C, Nguyen DT, DeForge LE, Remick DG: Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia. J Immunol 148:2724-2730, 1992.
30. Hadjiminas DJ, McMasters KM, Peyton JC, Cook MD, Cheadle WG: Passive immunization against tumor necrosis factor and interleukin-1 fails to reduce lung neutrophil sequestration in chronic sepsis. Shock 2:376-380, 1994.
31. Bagby G J, Plessala KJ, Wilson LA, Thompson JJ, Nelson S: Divergent efficacy of antibody to tumor necrosis factor-α in intravascular and peritonitis models of sepsis. J Infect Dis 163:83-88, 1991.
32. Remick D, Manohar P, Bolgos G, Rodriguez J, Moldawer L, Wollenberg G: Blockade of tumor necrosis factor reduces lipopolysaccharide lethality, but not the lethality of cecal ligation and puncture. Shock 4:89-95, 1995.
33. Zisman DA, Kunkel SL, Stricter RM, Gauldie J, Tsai WC, Bramson J, Wilkowski JM, Bucknell KA, Standiford TJ: Anti-interleukin-12 therapy protects mice in lethal endotoxemia but impairs bacterial clearance in murine Eschericia coli peritoneal sepsis. Shock 8:349-356, 1997.
34. Steinhauser ML, Hogaboam CM, Lukacs NW, Stricter RM, Kunkel SL: Multiple roles for IL-12 in a model of acute septic peritonitis. J Immunol 162:5437-5443, 1999.
35. Taylor-Robinson AW, Liew FY, Severn A, Xu D, McSorley SJ, Garside P, Padron J, Phillips RS: Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells. Eur J Immunol 24:980-984, 1994.
36. Marcinkiewicz J, Grabowska A, Chain BM: Is there a role for nitric oxide in regulation of T cell secretion of IL-2? J Immunol 156:4617-4621, 1996.
37. Bianchi M, Ulrich P, Bloom O, Meistrell III M, Zimmerman GA, Donnelley T, Bucala R, Sherry B, Manogue KR, Tortolani AJ, Cerami A, Tracey KJ: An inhibitor of macrophage arginine transport and nitric oxide production (CNI-1493) prevents acute inflammation and endotoxin lethality. Mol Med 1:254-266, 1995.
38. Caiviano M: Role of MAP kinase cascades in inducing arginine transporters and nitric oxide synthetase in RAW264 macrophages. FEBS Lett 429: 249-253, 1998.
39. Ajizian SJ, English BK, Meals EA: Specific inhibitors of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and interferon-γ. J Infect Dis 179:939-944, 1999.
40. Ayala A, O'Neill PJ, Uebele SA, Herdon CD, Chaudry IH: Mechanism of splenic immunosuppression during sepsis: key role of Kupffer cell mediators. J Trauma 42:882-888, 1997.
41. Bode JG, Peters-Regehr T, Schliess F, Haussinger D: Activation of mitogen-activated protein kinases and IL-6 release in response to lipopolysaccharides in Kupffer cells is modulated by anioosmolarity. J Hepatol 28: 795-802, 1998.
42. Gallagher TF, Seibel GL, Kassis S, Laydon JT, Blumenthal MJ, Lee JC, Lee D, Boehm JC, Fier-Thompson SM, Abt JW, Soreson ME, Smietana JM, Hall RF, Garigipati RS, Bender PE, Erhard KF, Krog AJ, Hofmann GA, Sheldrake PL, McDonnell PC, Kumar S, Young PR, Adams JL: Regulation of stress-induced cytokine production by pyridinylimidazoles: inhibition of CSBP kinase. Bioorganic Med Chem 5:49-64, 1997.
43. Marshall LA, Hansbury MJ, Bolognese BJ, Gum RJ, Young PR, Mayer RJ: Inhibitors of the p38 mitogen-activated kinase modulate IL-4 induction of low affinity IgE receptor (CD23) in human monocytes. J Immunol 161:6005-6013, 1999.